Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?
Regeneron Pharmaceuticals, Inc. (REGN), is a biotechnology company based in Tarrytown, New York, with a market capitalization of around $82.6 billion. The company specializes in discovering, developing, manufacturing and commercializing transformative medicines for a wide range of serious diseases, including eye diseases, allergies and inflammation, cancer, cardiovascular, neurological, infectious, hematological and rare diseases. Companies with…